https://github.com/theronic/eacl – EACL: Enterprise Access ControL is a situated ReBAC authorization library inspired by SpiceDB, built in Clojure and backed by Datomic Pro, Datahike, Datalevin or DataScript.
"Situated" here means that permissions are just data that co-exist with your application data. This has several advantages: reduced network latency, strong local consistency and opportunities for real-time view maintenance.
Doubtful. It will reduce some user count, but most people won’t care. And they probably spend more supporting the feature than they gain from the Gmail users that actually use the feature.
Most Ketamine users are unaware that even occasional usage causes untreatable ulcerative cystitis, a.k.a. Ketamine Bladder Syndrome. Ketamine thins the urothelium while increasing the collagen to smooth muscle ratio and exacerbating interstitial fibrosis. The syndrome is untreatable and causes serious problems down the line.
So, for anyone thinking of using Ketamine on the regular or even monthly, there is good evidence that EGCG (epigallocatechin gallate) administered 30 minutes before prevents KBS (Ketamine Bladder Syndrome), in rats: https://www.sciencedirect.com/science/article/pii/S187952261...
This promising rat study from 2015 shows that EGCG extracted from green tea has a protective effect on the bladder, reversing ketamine-induced damage to control levels. So if you are taking ketamine for major depression or recreationally, taking EGCG before may prevent long-term bladder damage.
Summary from the study:
# Objective
To investigate the protective effect of green tea epigallocatechin gallate (EGCG) on long-term ketamine-induced ulcerative cystitis (KIC) using a ketamine addiction rat model.
# Materials and methods
Thirty Sprague-Dawley rats were divided into three groups which received saline, ketamine (25 mg/kg/d), or ketamine combined with EGCG (10 μM/kg) for a period of 28 days. In each group, cystometry and a metabolic cage micturition pattern study were performed weekly. Masson's trichrome study was done to evaluate the morphologic changes. Western blot analyses were carried out to examine the expressions of inflammatory protein [transforming growth factor-β (TGF-β)] and fibrosis proteins (fibronectin and type I collagen) in bladder tissues.
# Results
Chronic ketamine treatment resulted in bladder hyperactivity with a significant increase in micturition frequency and a decrease in bladder compliance. These alterations in micturition pattern were accompanied by increases in the expressions of inflammatory and fibrosis markers, TGF-β, fibronectin, and type I collagen after long-term ketamine treatment. Masson's trichrome stain showed that ketamine treatment decreased urothelium thickness while increasing the collagen to smooth muscle ratio and exacerbating interstitial fibrosis. By contrast, simultaneous EGCG and ketamine treatment reversed ketamine-induced damage to almost control levels, showing the protective effect of EGCG.
I have researched this in the past and I couldn’t find any good studies on therapeutic and recreational doses in relation to KBS. Everything I’ve read is similar to that study. 25mg/kg/d for 28 days is a very large and very frequent dose. Do you have any links regarding monthly use?
It matters because it means that lab could not train that model without distilling another frontier model, and their progress would slow once they get properly cut-off. If I funded that lab, I would want to know that.
reply